CC
Corton Capital Portfolio holdings
AUM
$85.9M
1-Year Return
50.75%
This Quarter Return
+19.06%
1 Year Return
+50.75%
3 Year Return
+186.03%
5 Year Return
–
10 Year Return
–
AUM
$174M
AUM Growth
-$31.4M
(-15%)
Cap. Flow
-$52.9M
Cap. Flow
% of AUM
-30.34%
Top 10 Holdings %
Top 10 Hldgs %
48.99%
Holding
691
New
222
Increased
56
Reduced
93
Closed
319
Top Buys
| 1 |
Palantir
PLTR
|
$635K |
| 2 |
Progressive
PGR
|
$585K |
| 3 |
Applied Materials
AMAT
|
$522K |
| 4 |
United Natural Foods
UNFI
|
$521K |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$515K |
Top Sells
| 1 |
IGMS
IGM Biosciences
IGMS
|
$1.1M |
| 2 |
Root
ROOT
|
$1.03M |
| 3 |
CareDx
CDNA
|
$929K |
| 4 |
Entrada Therapeutics
TRDA
|
$924K |
| 5 |
Southern Company
SO
|
$883K |
Sector Composition
| 1 | Technology | 56.1% |
| 2 | Healthcare | 9.35% |
| 3 | Financials | 7.08% |
| 4 | Industrials | 6.17% |
| 5 | Consumer Discretionary | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Compass
COMP
$5.07B
| $129K | 0.07% |
+22,133
| New | +$129K |
|
327
James River Group
JRVR
$249M
| $129K | 0.07% |
26,537
-23,216
| -47% | -$113K |
|
328
Xperi
XPER
$284M
| $127K | 0.07% |
+12,386
| New | +$127K |
|
329
Compass Minerals
CMP
$784M
| $127K | 0.07% |
+11,300
| New | +$127K |
|
330
Array Technologies
ARRY
$1.37B
| $127K | 0.07% |
+20,979
| New | +$127K |
|
331
B&G Foods
BGS
$374M
| $126K | 0.07% |
+18,320
| New | +$126K |
|
332
Payoneer
PAYO
$2.4B
| $125K | 0.07% |
12,496
-17,925
| -59% | -$180K |
|
333
TTEC Holdings
TTEC
$183M
| $124K | 0.07% |
+24,906
| New | +$124K |
|
334
Hertz
HTZ
$1.7B
| $124K | 0.07% |
33,753
+13,879
| +70% | +$50.8K |
|
335
Enviri
NVRI
$948M
| $123K | 0.07% |
16,001
+5,400
| +51% | +$41.6K |
|
336
DHT Holdings
DHT
$2B
| $122K | 0.07% |
+13,183
| New | +$122K |
|
337
Lifetime Brands
LCUT
$97.2M
| $122K | 0.07% |
+20,722
| New | +$122K |
|
338
Cognyte Software
CGNT
$657M
| $118K | 0.07% |
13,592
-29,855
| -69% | -$258K |
|
339
Immatics
IMTX
$761M
| $110K | 0.06% |
15,538
-9,901
| -39% | -$70.4K |
|
340
Fulcrum Therapeutics
FULC
$414M
| $110K | 0.06% |
23,498
-34,101
| -59% | -$160K |
|
341
OptimizeRx
OPRX
$349M
| $110K | 0.06% |
+22,610
| New | +$110K |
|
342
Hain Celestial
HAIN
$164M
| $105K | 0.06% |
17,130
-31,366
| -65% | -$193K |
|
343
Biomea Fusion
BMEA
$114M
| $105K | 0.06% |
+27,143
| New | +$105K |
|
344
Herbalife
HLF
$1.02B
| $105K | 0.06% |
15,641
-20,834
| -57% | -$139K |
|
345
American Vanguard Corp
AVD
$159M
| $103K | 0.06% |
+22,350
| New | +$103K |
|
346
Regenxbio
RGNX
$490M
| $103K | 0.06% |
+13,276
| New | +$103K |
|
347
Quad
QUAD
$334M
| $103K | 0.06% |
+14,723
| New | +$103K |
|
348
Peloton Interactive
PTON
$3.27B
| $102K | 0.06% |
+11,709
| New | +$102K |
|
349
Olema Pharmaceuticals
OLMA
$570M
| $101K | 0.06% |
17,308
-1,838
| -10% | -$10.7K |
|
350
MindMed
MNMD
$702M
| $100K | 0.06% |
+14,416
| New | +$100K |
|